NCLT Approves Titan Pharmplus Titan Labs Amalgamation

NCLT Mumbai Bench approves Scheme of Amalgamation for Titan Pharmplus into its parent Titan Laboratories.
Tribunal dispenses with meetings for shareholders and creditors due to 100% consents and over 90% creditor approval.
Rationale includes operational synergies, cost savings, and consolidation of financial resources into one entity.
Appointed Date for the Scheme is fixed as 1st October 2025, subject to final NCLT approval.